Cargando…

Preclinical models for Type 1 Diabetes Mellitus - A practical approach for research

Numerous preclinical models have been developed to advance biomedical research in type 1 diabetes mellitus (T1DM). They are essential for improving our knowledge of T1DM development and progression, allowing researchers to identify potential therapeutic targets and evaluate the effectiveness of new...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Xi, Rao, Guocheng, Li, Xinqiong, Tong, Nanwei, Tian, Yan, Fu, Xianghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583179/ https://www.ncbi.nlm.nih.gov/pubmed/37859703 http://dx.doi.org/10.7150/ijms.86566

Ejemplares similares

Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications
por: Liu, Jing, et al.
Publicado: (2022)

Signaling pathways and intervention for therapy of type 2 diabetes mellitus
por: Cao, Rong, et al.
Publicado: (2023)

Associations of composite dietary antioxidant index with cardiovascular disease mortality among patients with type 2 diabetes
por: Yang, Chan, et al.
Publicado: (2023)

Modular characteristics and mechanism of action of herbs for type 2 diabetes treatment in Chinese medicine
por: Yang, Chan, et al.
Publicado: (2023)

Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology
por: Rao, Guocheng, et al.
Publicado: (2023)

Key circRNAs, lncRNAs, and mRNAs of ShenQi Compound in Protecting Vascular Endothelial Cells From High Glucose Identified by Whole Transcriptome Sequencing
por: Yang, Chan, et al.
Publicado: (2023)

Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function
por: Xu, Haixia, et al.
Publicado: (2020)

Ameliorative Effect of Berberine on Neonatally Induced Type 2 Diabetic Neuropathy via Modulation of BDNF, IGF-1, PPAR-γ, and AMPK Expressions
por: Zhou, Guangju, et al.
Publicado: (2019)

Efficacy and safety of dulaglutide in patients with type 2 diabetes: a meta-analysis and systematic review
por: Zhang, Lin, et al.
Publicado: (2016)

Diabetic Encephalopathy in a Preclinical Experimental Model of Type 1 Diabetes Mellitus: Observations in Adult Female Rat
por: Falvo, Eva, et al.
Publicado: (2023)

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies
por: Rangel, Érika B., et al.
Publicado: (2019)

Early-onset of type 2 diabetes mellitus is a risk factor for diabetic nephropathy progression: a biopsy-based study
por: Wu, Yucheng, et al.
Publicado: (2021)

Content of Carbonyl Compounds and Parameters of Glutathione Metabolism in Men with Type 1 Diabetes Mellitus at Preclinical Stages of Diabetic Nephropathy
por: Darenskaya, M. A., et al.
Publicado: (2021)

Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study
por: Mo, Dan, et al.
Publicado: (2019)

Potential Therapeutic Targeting Neurotransmitter Receptors in Diabetes
por: Pan, Xiaohui, et al.
Publicado: (2022)

Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus
por: Kolodka, Tadeusz, et al.
Publicado: (2014)

Pharmacological approaches to the prevention of type 2 diabetes mellitus
por: Majety, Priyanka, et al.
Publicado: (2023)

Application of Berberine on Treating Type 2 Diabetes Mellitus
por: Pang, Bing, et al.
Publicado: (2015)

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice
por: Venkatachalapathy, Poongothai, et al.
Publicado: (2021)

Association of Serum PSP/REG Iα with Renal Function in Type 2 Diabetes Mellitus
por: Zhu, Huimin, et al.
Publicado: (2020)

Colorectal Cancer Research: Basic, Preclinical, and Clinical Approaches
por: Beaulieu, Jean-François
Publicado: (2020)

Approaches in type 1 diabetes research: A status report
por: Raha, Oindrila, et al.
Publicado: (2009)

Evaluation of the HbA1c Reduction Cut Point for a Nonglycemic Effect on Cardiovascular Benefit of Hypoglycemic Agents in Patients with Type 2 Diabetes Based on Endpoint Events
por: Wu, Yuchao, et al.
Publicado: (2018)

Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes
por: Postigo-Fernandez, Jorge, et al.
Publicado: (2022)

Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials
por: Zhang, Fang, et al.
Publicado: (2017)

Effectiveness of Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion for Children with Type 1 Diabetes Mellitus in Clinical Practice
por: Gong, Chun-xiu, et al.
Publicado: (2014)

Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease
por: Zou, Yutong, et al.
Publicado: (2022)

2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
por: Kim, Mee Kyoung, et al.
Publicado: (2019)

Multi-omics: Opportunities for research on mechanism of type 2 diabetes mellitus
por: Wang, Shuai, et al.
Publicado: (2021)

Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
por: Su, Jingqian, et al.
Publicado: (2023)

Comparison of gene expression in cynomolgus monkeys with preclinical type II diabetes induced by different high energy diets
por: Jin, Li‐Sha, et al.
Publicado: (2019)

Mechanisms of Post-Pancreatitis Diabetes Mellitus and Cystic Fibrosis-Related Diabetes: A Review of Preclinical Studies
por: Gál, Eleonóra, et al.
Publicado: (2021)

An HNSCC syngeneic mouse model for tumor immunology research and preclinical evaluation
por: Fu, You, et al.
Publicado: (2020)

Gene expression profile in obesity and type 2 diabetes mellitus
por: Das, Undurti N, et al.
Publicado: (2007)

The Threshold of the Severity of Diabetic Retinopathy below Which Intensive Glycemic Control Is Beneficial in Diabetic Patients: Estimation Using Data from Large Randomized Clinical Trials
por: Liu, Yuqi, et al.
Publicado: (2020)

Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial
por: Zhang, Fang, et al.
Publicado: (2021)

Improvement of Diabetes Mellitus After Colorectal Cancer Surgery: A Retrospective Study of Predictive Factors For Type 2 Diabetes Mellitus Remission and Overall Survival
por: Peng, Dong, et al.
Publicado: (2021)

Altered dynamic functional architecture in type 2 diabetes mellitus
por: Li, Yifan, et al.
Publicado: (2023)

Conflicts of Interest among Authors of Clinical Practice Guidelines for Glycemic Control in Type 2 Diabetes Mellitus
por: Norris, Susan L., et al.
Publicado: (2013)

A Hybrid Approach for Modeling Type 2 Diabetes Mellitus Progression
por: Perveen, Sajida, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_on8cnt8mes6pl2v3s19dtgsiog